Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
202 studies found for:    Open Studies | "Protozoan Infections"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Protozoan Infections"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Unknown  Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Conditions: Trypanosomiasis;   Trypanosomiasis, African;   Protozoan Infections;   Parasitic Diseases
Interventions: Drug: SCYX-7158;   Drug: Placebo
2 Recruiting Parasitic Infections of the Gastrointestinal Tract
Conditions: Amebiasis;   Cryptosporidiosis;   Giardiasis;   Parasitic Disease;   Parasitic Intestinal Disease;   Gastrointestinal Helminth Infections
Intervention:
3 Unknown  Babesia Testing in Blood Donors
Condition: Transfusion Transmitted Babesiosis
Intervention: Biological: B.microti diagnostic blood tests
4 Not yet recruiting Trial of Ceramic Water Filters to Reduce Cryptosporidium Infection in Kenya
Conditions: Cryptosporidium;   Cryptosporidiosis;   Waterborne Disease;   Diarrheal Disease
Intervention: Other: Ceramic water filter
5 Recruiting Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Condition: Toxoplasmosis
Interventions: Drug: Leucovorin calcium;   Drug: Pyrimethamine;   Drug: Spiramycin;   Drug: Sulfadiazine
6 Recruiting Prevention of Congenital Toxoplasmosis With Pyrimethamine + Sulfadiazine Versus Spiramycine During Pregnancy
Condition: Congenital Toxoplasmosis
Interventions: Drug: Pyrimethamine/Sulfadiazine;   Drug: Spiramycine
7 Unknown  Evaluation of the Efficacy and Safety of Inhaled Nitric Oxide as Adjunctive Treatment for Cerebral Malaria in Children
Condition: Cerebral Malaria
Interventions: Drug: inhaled nitric oxide;   Drug: Placebo
8 Recruiting Assessment of Two Therapeutic Strategies in the Treatment of Children With Congenital Toxoplasmosis
Condition: Congenital Toxoplasmosis
Interventions: Procedure: reducing treatment to 3 months;   Procedure: registered length of treatment
9 Unknown  Randomized Trial of Erythropoietin During Cerebral Malaria
Condition: Cerebral Malaria
Interventions: Drug: Placebo;   Drug: Erythropoietin
10 Recruiting A Dose-Escalation, Safety and Feasibility Study of Enteral Levetiracetam for Seizure Control in Pediatric Cerebral Malaria
Conditions: Seizure;   Epilepsy;   Cerebral Malaria
Interventions: Drug: Oral Levetiracetam;   Drug: Standard AED
11 Recruiting Observational Program Neo-Penotran® Forte
Conditions: Vaginal Candidiasis;   Bacterial Vaginosis;   Trichomonal Vaginitis
Intervention: Drug: Metronidazole/Miconazole (Neo-Penotran Forte, BAY86-5276)
12 Recruiting Selenium Treatment and Chagasic Cardiopathy (STCC)
Condition: Chagas Disease
Interventions: Drug: Selenium;   Drug: Placebo (for Selenium)
13 Recruiting A Clinical Trial of the PfSPZ Vaccine Administered by Direct Venous Inoculation in Healthy Malaria-Naïve Adults: Heterologous vs. Homologous Controlled Human Malaria Infection and Reduction in Number of Doses
Condition: Malaria
Intervention: Biological: PfSPZ Vaccine
14 Recruiting Miltefosine to Treat Mucocutaneous Leishmaniasis
Conditions: Leishmaniasis, Mucocutaneous;   Cutaneous Leishmaniasis
Intervention: Drug: miltefosine
15 Recruiting Providers' Compliance to Malaria Treatment
Condition: Malaria
Intervention: Other: SMS reminders
16 Recruiting A Safety and Efficacy Study of Concomitant Administration of ChAd63/MVA ME-TRAP + RTS,S
Condition: Plasmodium Falciparum Malaria
Interventions: Biological: RTS,S/AS01B (50mcg of RTS,S and standard adult dose of AS01);   Biological: RTS,S/AS01B (10mcg of RTS,S and one fifth of the standard dose of AS01);   Biological: ChAd63 ME-TRAP (5 x 10^10 vp);   Biological: MVA ME-TRAP (2 x 10^8 pfu)
17 Not yet recruiting A Prospective, Phase II Clinical Trial for Evaluation of G- CSF (Colony Stimulating Factor) in Patients With Chronic Chagas Cardiomyopathy
Condition: Chronic Chagasic Myocarditis
Interventions: Drug: Treatment with G-CSF (Granulocyte colony stimulating factor);   Drug: Placebo saline
18 Not yet recruiting Prospective Observational Study of Intralesional Treatment With Pentostam in Cutaneous Leishmaniasis Israeli Patients
Condition: Cutaneous Leishmaniasis
Intervention: Drug: Pentostam
19 Unknown  Evaluation of Fosmidomycin and Clindamycin in the Treatment of Acute Uncomplicated Plasmodium Falciparum Malaria
Condition: Malaria
Intervention: Drug: Fosmidomycin and clindamycin
20 Not yet recruiting A Surveillance Study of Diseases Specified as Adverse Events of Specific Interest (AESI) and Serious Adverse Events (SAEs) in Children in Africa Prior to Implementation of the RTS,S/AS01E Candidate Vaccine
Condition: Malaria
Interventions: Procedure: Lumbar puncture;   Procedure: Venous blood sample

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years